Sunday, November 24, 2013

International Marketing for Your Start-up

Start-Up Marketing Advantages of an International Event 


Grow your network

Such International events are an excellent way to grow your network personally and make new connections. In such events if you have a chance to get connected with even a few professionals then often they themselves are in a position to connect  you with potential clients. For example a professional from an event organizing product company that we met is already in connection with many International Pharma industry professionals who could be potential clients for S&N Consultancy.


Awareness of the market

There are many products that make businesses simple whereby a lot of day to day tasks can be managed easily without any hired help, making them also cost effective. This is especially relevant for startups given their limited resources and time. Global marketing events are an excellent source of such information.  It gives a good overview of the ease with which events can be organized.


Brand Promotion

You yourself get the chance to interact with the world and promote your brand. Personal interaction is one of the best ways to promote and what better chance than to meet so many International professionals all under one roof to do that!  



Interpersonal Advertising

This way you are directly reaching out to people and showing them what you are! We got to directly talk about our S&N Consultancy and the services we offer to those we met and we hope that they will remember us and spread the word.


Build your confidence

To be able to attend International events in the capacity which you really want other people to recognize you in is a major Confidence booster.  It was a matter of pride for us to be invited to this international event. That we are slowly gaining recognition in the business world is surely one of the best milestones at this stage for S&N Consultancy as a business with budding global aspirations. Being invited to an International event in one of the most beautiful venues with so much history behind it, in the heart of Brussels adds yet another dimension to our global growth.   


Janhavi Atre
Head, Sales and Marketing
SAM & NEEL Consultancy

Monday, October 28, 2013

Why does the Big Pharma continue with the Old R&D Business Models?


Big Pharma: The Emperor’s New Clothes


The old clothes have served their time well. The Emperor now needs to take them off, place them aside with due respect and be naked. So that he can put on new clothes that serve the present and the future to come.

I am passionate about what the Pharma industry stands for at its heart; just like a vast majority of a world population, that has chosen to be attached to this industry for its meaning, purpose and livelihood.
 
There is a fundamental flaw in the thought that governs the present of the Big Pharma today; that prevents this vast majority from accessing the continuum of this passion of the Big Pharma, into the decades of 2015-25 and beyond. This flaw is in the collective sub-conscious of the current Big Pharma leadership that defines its existence and meaning through its deep and life-long; emotional, financial and beyond investments in the old model of Big Pharma R&D and business, which has served its time well; but is now slipping out of its fingers like sand.
 
The current Big Pharma leadership has a self-serving bias to hold onto the old Big Pharma model of R&D and business of the yesteryears.

 
Hence we hear it speak about the ‘dying model of Big Pharma business’, ‘end of the block-buster model’, ‘burning platform theory’ etc. And even when they do talk about the future, it is mere lip-service; in reality all efforts are still focused on mere incremental solutions for the old models. Their current effort is defeated by the classic bootstrap paradox.
 
We don’t hear this leadership use the language of a ‘new era’, ‘a new beginning’, ‘a rising dawn (if you may)’; for the Pharma industry of 2015-25 and beyond. Because the vested interest and field of vision of the current generation of retiring leadership is limited by the past that defines its existence; and has little real interest connected with the Pharma industry beyond its retirement.
 
It is the next generation of leadership, for whom the decades of 2015-25 and beyond will be the definition of their existence, meaning and purpose; that will use the language of a ‘new beginning’ for the Pharma industry. It is time the old leadership gracefully hands over the baton to the new and takes its place as a wise mentor, advisor for the next generation of leaders.

The heart and soul of the Pharma industry continues to live on, stronger. The time is here, not for the end of the Pharma industry, but the end of the minds and thoughts that defined the old and fading models of R&D and business.
 



It is also time for a new generation of leadership, a new mind that is already busy visualizing, imagining and creating a vision for a new beginning for the Pharma industry of the future decades of 2015-25 and beyond; and a mind that has a healthy amount of disrespect for the current models of R&D and business.





The Emperor needs to shed off its old clothes that have served their time well, and accept his nakedness. So that he can put on new clothes that match the ‘times they are a changing’ of today and tomorrow.